FTM
AKRO

First Turn Management’s Akero Therapeutics AKRO Stock Holding History

First Turn Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-397,010
Closed -$18.9M – 36
2025
Q3 		$18.9M Buy
397,010
+282,456
+247% +$13.7M 2.83% 17
2025
Q2 		$6.11M Buy
+114,554
New +$5.21M 1.14% 32

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Turn Management's AKRO Position: Q4 2025 in Review

First Turn Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 397,010 shares — an estimated $18.9M sold.

First Turn Management first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $18.9M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • First Turn Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • First Turn Management sold 397,010 Akero Therapeutics shares in Q4 2025, an estimated $18.9M.
  • First Turn Management first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • First Turn Management's Akero Therapeutics position peaked at $18.9M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on First Turn Management's 13F filing for Q4 2025, filed 13 Feb 2026.